Lunchtime ASX small cap wrap: Who’s feeding the pigs today?

Link copied to
clipboard

This chart, from a recent Wall Street Journal story, shows — over time — how many US IPOs are losing money:

Right now, it’s a lot. As you can see, the last time this “clear danger sign” popped up was on the brink of the dot-com collapse in 1999, says Brad Lamensdorf, portfolio manager for AdvisorShares Ranger Equity Bear ETF.

“When pigs squeal, feed them,” Lamensdorf says.

In other words, stuff the stock market — or feed the pigs — with overpriced companies while the public still has an appetite for risk.

“Over-priced IPOs usually occur toward the end of a long bull run when stocks in general become very overpriced,” Lamensdorf says.

“Why does this happen? Generally, because investors have lost their sense of reality. They are willing to buy stocks on hyped stories instead of the facts.”

Still, for now things are looking rosy. US share markets closed at record highs on Thursday, with the US-China phase one trade deal boosting investor sentiment and fresh economic data generally meeting (or exceeding) expectations. The ASX200 and Small Ord Indexes followed the US up in morning trade.

Here are all your key small cap winners and losers in morning trade for Friday, January 17:

GOING UP:

G Medical (ASX:GMV) +27.78%

The Biotech stock jumped sharply after announcing it had completed the necessary clinical trials and will now lodge a submission for approval to use of its Prizma device in the massive Chinese market.

“The company will shortly lodge the required documentation to the regulator and we are confident that NMPA approval will be received towards the middle of the year,” chief exec Dr Yacov Geva says.

“Following this, the provisions for our device sales and services are expected to be able to materialise quickly via our existing established in-country partners, as well as to allow for additional partnerships to be explored.” 

READ: G Medical had a rough year, but it’s determined to sell hi-spec smartphone monitors to China and the US

Creso Pharma (ASX:CPH) +26.27%

Creso impressed the market with strong December quarter revenues of almost $2m.

For the full year 2019, unaudited revenues were $3.651m “showing strong growth in market acceptance for Creso Pharma products and successful penetration of new markets”, chief exec Dr Miri Halperin Wernli says.

“The company’s products are now sold across Europe and Oceania and will soon be available in South Africa.”

READ:  Cannabis stocks guide — Here’s everything you need to know

Here are the best performing ASX small cap stocks at 12pm Friday January 17:

Swipe or scroll to reveal the full table. Click headings to sort.

GOING DOWN:

Pantoro (ASX:PNR) -15.38%

Gold producer Pantoro (ASX:PNR) took a +15 per cent hit after releasing a shaky looking quarter report yesterday — just 9,403oz of gold was produced from the halls creek operation at a very high all in sustaining cost of $1,940/oz.

On the upside, Pantoro had $31.7m in cash and gold at the end of the quarter “and remains debt free”. Silver linings and all that.

READ: Tim Treadgold — Pantoro is trying to solve the puzzle at one of Australia’s richest goldfields

The rest of the losers column was predominantly driven by ‘no-news’, sub $10m market cap exploration plays like Moreton Resources (ASX:MRV), New Age Exploration (ASX:NAE), Inca Minerals (ASX:ICG), and Viking Mines (ASX:VKA).

Here are the worst performing ASX small cap stocks at 12pm Friday January 17:

Swipe or scroll to reveal the full table. Click headings to sort.

At Stockhead, we tell it like it is. While Creso Pharma is a Stockhead advertiser, it did not sponsor this article.

share

• 
• 
• 
• 

Link copied to
clipboard

SUBSCRIBE

Get the latest Stockhead news delivered free to your inbox.

Name*

Email*

This field is hidden when viewing the form

Email Lists

Morning Update

Lunch Update

Market Close Update

Weekend Update

Spotlight

Phone

This field is for validation purposes and should be left unchanged.

It's free. Unsubscribe whenever you want.

By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.

You might be interested in

Mining

Record gold prices are the ‘rising tide’ that may rerate junior explorers

February 14, 2025 | Bevis Yeo

Mining

As bullion booms ASX gold miners could soon be raking in $1 billion a quarter

February 4, 2025 | Josh Chiat

Mining

Monster or Mouse: Gold miners joined the big leagues as TEN ASX stocks became Monsters of Rock in 2024

January 2, 2025 | Josh Chiat